Camila Scharf

Dr. Camila Scharf

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2025 in Cancers
Verified
Journal Article
Open access
PDF file
MMMichele Manganelli
Michele Manganelli
GSGiorgio Stabile
Giorgio Stabile
CSCamila Scharf
Camila Scharf
ABAntonio Podo Brunetti
Antonio Podo Brunetti
Giovanni PaolinoGiovanni Paolino
Giovanni Paolino
Franco RongiolettiFranco Rongioletti
Franco Rongioletti
Melanoma, the most aggressive form of skin cancer, still represents a significant and growing public health concern. Ultraviolet radiation (UVR) is considered the primary driver of melanoma, although genetic predisposition also plays a critical role. This review explores the intricate molecular mechanisms by which UVR-induced photodamage contributes to melanoma development. We examine epidemiological evidence linking UV exposure to increased risk, detailing how UVR damage to DNA triggers inflammatory responses and impairs DNA repair mechanisms. Specifically, we discuss the roles of nucleotide excision repair (NER) and base excision repair (BER) in mitigating UV damage. The review further explores diagnostic and surgical implications for melanomas arising on sun-exposed skin. By synthesizing current evidence, this overview aims to deepen understanding of the complex relationship between UVR, photodamage, and melanoma, shedding light on the need for personalized preventive strategies to better stratify the risk and introduce behavioral changes to reduce skin photodamage.

1 September 2014 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PDF file
LRLarissa Montanheiro dos Reis
Larissa Montanheiro dos Reis
BLBrunno Zeni de Lima
Brunno Zeni de Lima
FZFernando da Cunha Zillo
Fernando da Cunha Zillo
CRCamila Makino Rezende
Camila Makino Rezende
LFLincoln Helder Zambaldi Fabricio
Lincoln Helder Zambaldi Fabricio
CSCamila Scharf
Camila Scharf
Mycetomas are a chronic skin infection characterized by perilesional edema, formation of sinus tracts, and discharge of purulent or seropurulent exudate containing grains. This report aims to demonstrate the clinical diagnosis (by dermoscopy) of a skin lesion that initially bared no clinical features of a mycetoma.

16 May 2022 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
CSCamila Scharf
Camila Scharf
GBGabriella Brancaccio
Gabriella Brancaccio
ASAlessandro Di Stefani
Alessandro Di Stefani
MFMaria Concetta Fargnoli
Maria Concetta Fargnoli
HKHarald Kittler
Harald Kittler
GAGiuseppe Argenziano
Giuseppe Argenziano

Verified
Journal Article
Open access
PDF file
LILucia Iavarone
Lucia Iavarone
RFRenato Franco
Renato Franco
FMFederica Zito Marino
Federica Zito Marino
GDGiuseppe D'Abbronzo
Giuseppe D'Abbronzo
Giuseppe ArgenzianoGiuseppe Argenziano
Giuseppe Argenziano
Gerardo CazzatoGerardo Cazzato
Gerardo Cazzato
Ocular melanoma is a rare but clinically significant malignancy, primarily comprising uveal and conjunctival subtypes. Although sharing some histopathological features with cutaneous melanoma, these tumours are characterized by distinct molecular and biological profiles with direct implications for prognosis and treatment. Uveal melanoma is predominantly driven by mutations in GNAQ and GNA11, along with alterations in BAP1, SF3B1, and EIF1AX, which are key prognostic determinants. Conversely, conjunctival and eyelid melanoma exhibits greater molecular similarity to cutaneous melanoma, commonly involving BRAF, NRAS, NF1, and TERT promoter mutations. Despite progress in the molecular characterization of these entities, metastatic disease continues to confer a poor prognosis, particularly in uveal melanoma. Ongoing research into the molecular basis of ocular melanoma is essential to advance targeted therapies and improve clinical outcomes. The aim of this review is to provide a comprehensive overview of ocular melanoma, with a particular focus on the molecular biology underlying its clinical behaviour and emerging therapeutic opportunities.

30 September 2021 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
PDF file
CSCamila Scharf
Camila Scharf
EBEugenia Veronica Di Brizzi
Eugenia Veronica Di Brizzi
SPS. Pellerone
S. Pellerone
MLM. Liguori
M. Liguori
CGC.M.R. Giorgio
C.M.R. Giorgio
Giuseppe ArgenzianoGiuseppe Argenziano
Giuseppe Argenziano
A 27-year-old woman presented to our Dermatology Unit referring an acute skin rash with no associated systemic symptoms. Three days before, the patient had taken the SARS-COV-2 vaccine (Comirnaty™ – BioNTech/Pfizer). Physical examination showed erythematous, ring-shaped plaques only surrounding several, but not all of her melanocytic nevi.

17 June 2022 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
EBEugenia Veronica Di Brizzi
Eugenia Veronica Di Brizzi
EMElvira Moscarella
Elvira Moscarella
CSCamila Scharf
Camila Scharf
Giuseppe ArgenzianoGiuseppe Argenziano
Giuseppe Argenziano
Vincenzo PiccoloVincenzo Piccolo
Vincenzo Piccolo